<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36273799</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1542-7714</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association</Title><ISOAbbreviation>Clin Gastroenterol Hepatol</ISOAbbreviation></Journal><ArticleTitle>Long-term Gastrointestinal Sequelae Following COVID-19: A Prospective Follow-up Cohort Study.</ArticleTitle><Pagination><StartPage>789</StartPage><EndPage>796.e1</EndPage><MedlinePgn>789-796.e1</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cgh.2022.10.015</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1542-3565(22)01004-7</ELocationID><Abstract><AbstractText Label="BACKGROUND &amp; AIMS">Coronavirus disease 2019 (COVID-19) is associated with long-term gastrointestinal sequelae; however, prospective longitudinal data are sparse. We prospectively studied the frequency, spectrum, and risk factors of post infection functional gastrointestinal disorders/disorders of gut-brain interaction (PI-FGID/DGBI) after COVID-19.</AbstractText><AbstractText Label="METHODS">Three hundred twenty cases with COVID-19 and 2 control groups, group A, 320 healthy spouses/family controls, and group B, 280 healthy COVID serology-negative controls, were prospectively followed up at 1, 3, and 6 months by using validated Rome IV criteria to evaluate the frequency of PI-FGID/DGBI.</AbstractText><AbstractText Label="RESULTS">Of 320 cases, at 1 month 36 (11.3%) developed FGID symptoms. Persistent symptoms were noted in 27 (8.4%) at 3 months and in 21 (6.6%) at 6 months. At 3 months, 8 (2.5%) had irritable bowel syndrome, 7 (2.2%) had functional diarrhea, 6 (1.9%) had functional dyspepsia, 3 (0.9%) had functional constipation, 2 (0.6%) had functional dyspepsia-IBS overlap, and 1 (0.3%) had functional abdominal bloating/distention. Among symptomatic individuals at 3 months, 8 (29.6%) were positive for isolated carbohydrate malabsorption, 1 (3.7%) was positive for post infection malabsorption syndrome, and 1 (3.7%) was positive for intestinal methanogen overgrowth. None of the healthy controls developed FGID up to 6 months of follow-up (P &lt; .01). Predictive factors at 3 and 6 months were severity of infection (P &lt; .01) and presence of gastrointestinal symptoms at the time of infection (P &lt; .01).</AbstractText><AbstractText Label="CONCLUSIONS">COVID-19 led to significantly higher number of new onset PI-FGID/DGBI compared with healthy controls at 3 and 6 months of follow-up. If further investigated, some patients can be diagnosed with underlying malabsorption.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 AGA Institute. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Golla</LastName><ForeName>Rithvik</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vuyyuru</LastName><ForeName>Sudheer</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kante</LastName><ForeName>Bhaskar</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Peeyush</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>David Mathew</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Makharia</LastName><ForeName>Govind</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kedia</LastName><ForeName>Saurabh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences, New Delhi, India. Electronic address: dr.saurabhkedia@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahuja</LastName><ForeName>Vineet</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences, New Delhi, India. Electronic address: vineet.aiims@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Gastroenterol Hepatol</MedlineTA><NlmUniqueID>101160775</NlmUniqueID><ISSNLinking>1542-3565</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004415" MajorTopicYN="Y">Dyspepsia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005767" MajorTopicYN="Y">Gastrointestinal Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043183" MajorTopicYN="Y">Irritable Bowel Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008286" MajorTopicYN="Y">Malabsorption Syndromes</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Functional Gastrointestinal Disorders (FGID)</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Post Infection-Irritable Bowel Syndrome (PI-IBS)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>23</Day><Hour>19</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36273799</ArticleId><ArticleId IdType="pmc">PMC9584755</ArticleId><ArticleId IdType="doi">10.1016/j.cgh.2022.10.015</ArticleId><ArticleId IdType="pii">S1542-3565(22)01004-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rokkas T. Gastrointestinal involvement in COVID-19: a systematic review and meta-analysis. Ann Gastroenterol. 2020;33:355&#x2013;365.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7315709</ArticleId><ArticleId IdType="pubmed">32624655</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y., Li X., Zhu B., et al. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat Med. 2020;26:502&#x2013;505.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7095102</ArticleId><ArticleId IdType="pubmed">32284613</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Xie Y., Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature [Internet. 2021;594:259&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Knight M., A&#x2019;Court C., et al. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Sperber A.D., Bangdiwala S.I., Drossman D.A., et al. Worldwide prevalence and burden of functional gastrointestinal disorders: results of Rome Foundation global study. Gastroenterology. 2021;160:99&#x2013;114.e3.</Citation><ArticleIdList><ArticleId IdType="pubmed">32294476</ArticleId></ArticleIdList></Reference><Reference><Citation>Klem F., Wadhwa A., Prokop L., et al. Prevalence, risk factors, and outcomes of irritable bowel syndrome after infectious enteritis: a systematic review and meta-analysis. Gastroenterology. 2017;152:1042&#x2013;1054.e1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5367939</ArticleId><ArticleId IdType="pubmed">28069350</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghoshal U.C., Gwee K.A. Post-infectious IBS, tropical sprue and small intestinal bacterial overgrowth: the missing link. Nat Rev Gastroenterol Hepatol. 2017;14:435&#x2013;441.</Citation><ArticleIdList><ArticleId IdType="pubmed">28513629</ArticleId></ArticleIdList></Reference><Reference><Citation>Thabane M., Marshall J.K. Post-infectious irritable bowel syndrome. World J Gastroenterol. 2009;15:3591&#x2013;3596.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2721231</ArticleId><ArticleId IdType="pubmed">19653335</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghoshal U.C., Srivastava D., Verma A., et al. Tropical sprue in 2014: the new face of an old disease. Curr Gastroenterol Rep. 2014;16:391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7088824</ArticleId><ArticleId IdType="pubmed">24781741</ArticleId></ArticleIdList></Reference><Reference><Citation>Drossman D.A. Functional gastrointestinal disorders: history, pathophysiology, clinical features, and Rome IV. Gastroenterology. 2016;150:1262&#x2013;1279.e2.</Citation><ArticleIdList><ArticleId IdType="pubmed">27144617</ArticleId></ArticleIdList></Reference><Reference><Citation>Drossman D.A., Tack J. Rome Foundation clinical diagnostic criteria for disorders of gut-brain interaction. Gastroenterology. 2022;162:675&#x2013;679.</Citation><ArticleIdList><ArticleId IdType="pubmed">34808139</ArticleId></ArticleIdList></Reference><Reference><Citation>Cascella M., Rajnik M., Aleem A., et al. StatPearls Publishing; Treasure Island, FL: 2022. Features, evaluation, and treatment of coronavirus (COVID-19)</Citation><ArticleIdList><ArticleId IdType="pubmed">32150360</ArticleId></ArticleIdList></Reference><Reference><Citation>Peled Y., Doron O., Laufer H., et al. D-xylose absorption test: urine or blood? Dig Dis Sci. 1991;36:188&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pubmed">1988262</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghoshal U.C. How to interpret hydrogen breath tests. J&#xa0;Neurogastroenterol Motil. 2011;17:312&#x2013;317.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3155069</ArticleId><ArticleId IdType="pubmed">21860825</ArticleId></ArticleIdList></Reference><Reference><Citation>Serra S., Jani P.A. An approach to duodenal biopsies. J&#xa0;Clin Pathol. 2006;59:1133&#x2013;1150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1860495</ArticleId><ArticleId IdType="pubmed">16679353</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbara G., Grover M., Bercik P., et al. Rome Foundation working team report on post-infection irritable bowel syndrome. Gastroenterology. 2019;156:46&#x2013;58.e7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6309514</ArticleId><ArticleId IdType="pubmed">30009817</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhary N.A., Truelove S.C. The irritable colon syndrome: a study of the clinical features, predisposing causes, and prognosis in 130 cases. Q&#xa0;J Med. 1962;31:307&#x2013;322.</Citation><ArticleIdList><ArticleId IdType="pubmed">13878459</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmulson M., Ghoshal U.C., Barbara G. Managing the inevitable surge of post&#x2013;COVID-19 functional gastrointestinal disorders. Am J Gastroenterol. 2021;116:4&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">33273261</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghoshal U.C., Ghoshal U., Rahman M.M., et al. Post-infection functional gastrointestinal disorders following coronavirus disease-19: a case&#x2013;control study. J&#xa0;Gastroenterol Hepatol. 2022;37:489&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8657345</ArticleId><ArticleId IdType="pubmed">34672022</ArticleId></ArticleIdList></Reference><Reference><Citation>V&#xe9;lez C., Paz M., Silvernale C., et al. Factors associated with chronic de novo post-coronavirus disease gastrointestinal disorders in a metropolitan US county. Clin Gastroenterol Hepatol. 2022;20:e1488&#x2013;e1492.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8529223</ArticleId><ArticleId IdType="pubmed">34687967</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackett J.W., Wainberg M., Elkind M.S.V., et al. Potential long coronavirus disease 2019 gastrointestinal symptoms 6 months after coronavirus infection are associated with mental health symptoms. Gastroenterology. 2022;162:648&#x2013;650.e2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8556689</ArticleId><ArticleId IdType="pubmed">34728186</ArticleId></ArticleIdList></Reference><Reference><Citation>Oshima T., Siah K.T.H., Yoshimoto T., et al. Impacts of the COVID-19 pandemic on functional dyspepsia and irritable bowel syndrome: a population-based survey. J&#xa0;Gastroenterol Hepatol. 2021;36:1820&#x2013;1827.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753727</ArticleId><ArticleId IdType="pubmed">33197076</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakov R., Dimitrova-Yurukova D., Snegarova V., et al. Increased prevalence of gastrointestinal symptoms and disorders of gut-brain interaction during the COVID-19 pandemic: an internet-based survey. Neurogastroenterol Motil. 2022;34</Citation><ArticleIdList><ArticleId IdType="pubmed">34145679</ArticleId></ArticleIdList></Reference><Reference><Citation>Noviello D., Costantino A., Muscatello A., et al. Functional gastrointestinal and somatoform symptoms five months after SARS-CoV-2 infection: a controlled cohort study. Neurogastroenterol Motil. 2022:34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8209890</ArticleId><ArticleId IdType="pubmed">34060710</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbosa da Luz B., de Oliveira N.M.T., Fran&#xe7;a dos Santos I.W., et al. An overview of the gut side of the SARS-CoV-2 infection. Intest Res. 2021;19:379&#x2013;385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8566822</ArticleId><ArticleId IdType="pubmed">33142370</ArticleId></ArticleIdList></Reference><Reference><Citation>Thabane M., Kottachchi D.T., Marshall J.K. Systematic review and meta-analysis: the incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther. 2007;26:535&#x2013;544.</Citation><ArticleIdList><ArticleId IdType="pubmed">17661757</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Mak J.W.Y., Su Q., et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022;71:544&#x2013;552.</Citation><ArticleIdList><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Takakura W., Pimentel M. Small intestinal bacterial overgrowth and irritable bowel syndrome: an update. Front Psychiatry. 2020;11:664.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7366247</ArticleId><ArticleId IdType="pubmed">32754068</ArticleId></ArticleIdList></Reference><Reference><Citation>Pimentel M., Morales W., Rezaie A., et al. Development and validation of a biomarker for diarrhea-predominant irritable bowel syndrome in human subjects. PLOS One. 2015;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4430499</ArticleId><ArticleId IdType="pubmed">25970536</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezaie A., Park S.C., Morales W., et al. Assessment of anti-vinculin and anti-cytolethal distending toxin B antibodies in subtypes of irritable bowel syndrome. Dig Dis Sci. 2017;62:1480&#x2013;1485.</Citation><ArticleIdList><ArticleId IdType="pubmed">28451914</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal O., Nohria S., Dhaliwal A.S., et al. Prevalence, overlap, and risk factors for Rome IV functional gastrointestinal disorders among college students in northern India. Indian J Gastroenterol. 2021;40:144&#x2013;153.</Citation><ArticleIdList><ArticleId IdType="pubmed">33226570</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford A.C., Spiegel B.M.R., Talley N.J., et al. Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2009;7:1279&#x2013;1286.</Citation><ArticleIdList><ArticleId IdType="pubmed">19602448</ArticleId></ArticleIdList></Reference><Reference><Citation>Rana S.V., Malik A. Hydrogen breath tests in gastrointestinal diseases. Indian J Clin Biochem. 2014;29:398&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4175689</ArticleId><ArticleId IdType="pubmed">25298621</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman M.M., Ghoshal U.C., Sultana S., et al. Long-term gastrointestinal consequences are frequent following sporadic acute infectious diarrhea in a tropical country: a prospective cohort study. Am J Gastroenterol. 2018;113 1363&#x2013;1175.</Citation><ArticleIdList><ArticleId IdType="pubmed">30171215</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstock L.B., Brook J.B., Walters A.S., et al. Mast cell activation symptoms are prevalent in long-COVID. Int J Infect Dis. 2021;112:217&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8459548</ArticleId><ArticleId IdType="pubmed">34563706</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynne P., Tahmasebi N., Gant V., et al. Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines. J&#xa0;Investig Med. 2022;70:61&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8494538</ArticleId><ArticleId IdType="pubmed">34611034</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall J.K., Thabane M., Borgaonkar M.R., et al. Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen. Clin Gastroenterol Hepatol. 2007;5:457&#x2013;460.</Citation><ArticleIdList><ArticleId IdType="pubmed">17289440</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanini B., Ricci C., Bandera F., et al. Incidence of post-infectious irritable bowel syndrome and functional intestinal disorders following a water-borne viral gastroenteritis outbreak. Am J Gastroenterol. 2012;107:891&#x2013;899.</Citation><ArticleIdList><ArticleId IdType="pubmed">22525306</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Bert N., Tan A.T., Kunasegaran K., et al. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature. 2020;584:457&#x2013;462.</Citation><ArticleIdList><ArticleId IdType="pubmed">32668444</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>